David Wai Chan (David W Chan)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 11

Top Venues

Nature communications

Clinical epigenetics

Cancers

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Danfeng Dong, Yuzhang Du, Xuefeng Fei, Hao Yang, Xiaofang Li, Xiaobao Yang, Junrui Ma, Shu Huang, Zhihui Ma, Juanjuan Zheng, David Wai Chan, Liyun Shi, Yunqi Li, Aaron Trent Irving, Xiangliang Yuan, Xiangfan Liu, Peihua Ni, Yiqun Hu, Guang-Xun Meng, Yibing Peng, Anthony Sadler, Dakang Xu
Inflammasome activity is controlled by ZBTB16-dependent SUMOylation of ASC. Nature communications 14 (1) (2023)
Danfeng Dong, Yuzhang Du, Xuefeng Fei, Hao Yang, Xiaofang Li, Xiaobao Yang, Junrui Ma, Shu Huang, Zhihui Ma, Juanjuan Zheng, David Wai Chan, Liyun Shi, Yunqi Li, Aaron Trent Irving, Xiangliang Yuan, Xiangfan Liu, Peihua Ni, Yiqun Hu, Guang-Xun Meng, Yibing Peng, Anthony Sadler, Dakang Xu
Inflammasome activity is controlled by ZBTB16-dependent SUMOylation of ASC. Nature communications 14 (1) (2023)
Danfeng Dong, Yuzhang Du, Xuefeng Fei, Hao Yang, Xiaofang Li, Xiaobao Yang, Junrui Ma, Shu Huang, Zhihui Ma, Juanjuan Zheng, David Wai Chan, Liyun Shi, Yunqi Li, Aaron Trent Irving, Xiangliang Yuan, Xiangfan Liu, Peihua Ni, Yiqun Hu, Guang-Xun Meng, Yibing Peng, Anthony Sadler, Dakang Xu
Inflammasome activity is controlled by ZBTB16-dependent SUMOylation of ASC. Nature communications 14 (1) (2023)
Danfeng Dong, Yuzhang Du, Xuefeng Fei, Hao Yang, Xiaofang Li, Xiaobao Yang, Junrui Ma, Shu Huang, Zhihui Ma, Juanjuan Zheng, David Wai Chan, Liyun Shi, Yunqi Li, Aaron Trent Irving, Xiangliang Yuan, Xiangfan Liu, Peihua Ni, Yiqun Hu, Guang-Xun Meng, Yibing Peng, Anthony Sadler, Dakang Xu
Inflammasome activity is controlled by ZBTB16-dependent SUMOylation of ASC. Nature communications 14 (1) (2023)
Danfeng Dong, Yuzhang Du, Xuefeng Fei, Hao Yang, Xiaofang Li, Xiaobao Yang, Junrui Ma, Shu Huang, Zhihui Ma, Juanjuan Zheng, David Wai Chan, Liyun Shi, Yunqi Li, Aaron Trent Irving, Xiangliang Yuan, Xiangfan Liu, Peihua Ni, Yiqun Hu, Guang-Xun Meng, Yibing Peng, Anthony Sadler, Dakang Xu
Inflammasome activity is controlled by ZBTB16-dependent SUMOylation of ASC. Nature communications 14 (1) (2023)
Mingo M H Yung, Michelle K Y Siu, Hextan Y S Ngan, David Wai Chan, Karen Kar-Loen Chan
Orchestrated Action of AMPK Activation and Combined VEGF/PD-1 Blockade with Lipid Metabolic Tunning as Multi-Target Therapeutics against Ovarian Cancers. International journal of molecular sciences 23 (12) (2022)
Xueyu Wang, Mingo M H Yung, Rakesh Sharma, Fushun Chen, Ying-Tung Poon, Wai-Yip Lam, Benjamin Li, Hextan Y S Ngan, Karen K L Chan, David Wai Chan
Epigenetic Silencing of miR-33b Promotes Peritoneal Metastases of Ovarian Cancer by Modulating the TAK1/FASN/CPT1A/NF-κB Axis. Cancers 13 (19) (2021)
Rui Liang, Mingo M H Yung, Fangfang He, Peili Jiao, Karen K L Chan, Hextan Y S Ngan, David Wai Chan
The Stress-Inducible BCL2A1 Is Required for Ovarian Cancer Metastatic Progression in the Peritoneal Microenvironment. Cancers 13 (18) (2021)
David Wai Chan, Wai-Yip Lam, Fushun Chen, Mingo M H Yung, Yau-Sang Chan, Wai-Sun Chan, Fangfang He, Stephanie S Liu, Karen K L Chan, Benjamin Li, Hextan Y S Ngan
Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancers. Clinical epigenetics 13 (1) (2021)
Jing-Jing Wang, Michelle Kwan-Yee Siu, Yu-Xin Jiang, Thomas Ho-Yin Leung, David Wai Chan, Huo-Gang Wang, Hextan Yuen-Sheung Ngan, Karen Kar-Loen Chan
A Combination of Glutaminase Inhibitor 968 and PD-L1 Blockade Boosts the Immune Response against Ovarian Cancer. Biomolecules 11 (12) (2021)
David Wai Chan, Wai-Yip Lam, Fushun Chen, Mingo M H Yung, Yau-Sang Chan, Wai-Sun Chan, Fangfang He, Stephanie S Liu, Karen K L Chan, Benjamin Li, Hextan Y S Ngan
Correction to: Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancers. Clinical epigenetics 13 (1) (2021)

David Wai Chan.css-eqlu8i{font-size:small;padding-left:4px;} (David W Chan)

Publication Activity (10 Years)

Top Topics

Top Venues

David Wai Chan (David W Chan)